Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Houston Assisted Reproductive Technologies, PLLC
FDA Inspection
•Houston Assisted Reproductive Technologies, PLLC•August 7, 2026

Houston Assisted Reproductive Technologies, PLLC – FDA Inspection, Aug 7, 2026

Record Details

This FDA Inspection record concerns Houston Assisted Reproductive Technologies, PLLC, with an inspection on August 7, 2026, issued by the Dallas District Office, covering biologics.

Company
Houston Assisted Reproductive Technologies, PLLC
Inspection Date
August 7, 2026
Product Type
Biologics
Office
Dallas District Office
Person
  • Elyshia Q. Danaher (Issuing Officer)
View Company Profile

ID · 53fc6d26-5f77-45ab-b9d6-6c4d8a98a2e1

Inspection Facts

Inspection number
1329880
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 1271.270(a)Records incomplete
  2. 21 CFR 1271.47(a)Design of procedures to ensure compliance
  3. 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
  4. 21 CFR 1271.50(a)Responsible person to determine, document
  5. 21 CFR 1271.55(b)(1)Statement re: certified testing lab
  6. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  7. 21 CFR 1271.75(a)(2)Risks associated with xenotransplantation
  8. 21 CFR 1271.85(a)Infection with communicable disease agents
  9. 21 CFR 1271.85(b)(2)SOP for release; reactive for CMV
  10. 21 CFR 1271.90(c)Eligibility not required--warning labels

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Houston Assisted Reproductive Technologies, PLLC

4
DateClassificationOfficeProject area
February 9, 2022NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
October 23, 2017VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 29, 2014NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
October 27, 2011NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Houston Assisted Reproductive Technologies, PLLC
  • FDA Inspection 1162284 - 2022-02-09
  • FDA Inspection 1029763 - 2017-10-23
  • FDA Inspection 898330 - 2014-09-29
  • FDA Inspection 751556 - 2011-10-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Houston Assisted Reproductive Technologies, PLLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.